Epstein Becker Green provided fraud and abuse compliance and contracting guidance to a biotechnology company utilizing artificial intelligence (AI) in its products. We reviewed our client’s contracts to ensure that each commercial engagement with physicians and health care practices reduced fraud and abuse-related risks.